Literature DB >> 19630765

Regulation of blood and vascular cell function by bioactive lysophospholipids.

A J Morris1, M Panchatcharam, H Y Cheng, L Federico, Z Fulkerson, S Selim, S Miriyala, D Escalante-Alcalde, S S Smyth.   

Abstract

Lysophosphatidic acid (LPA), its sphingolipid homolog sphingosine 1-phosphate (S1P) and several other related molecules constitute a family of bioactive lipid phosphoric acids that function as receptor-active mediators with roles in cell growth, differentiation, inflammation, immunomodulation, apoptosis and development. LPA and S1P are present in physiologically relevant concentrations in the circulation. In isolated cell culture systems or animal models, these lipids exert a range of effects that suggest that S1P and LPA could play important roles in maintaining normal vascular homeostasis and in vascular injury responses. LPA and S1P act on a series of G protein-coupled receptors, and LPA may also be an endogenous regulator of PPARgamma activity. In this review, we discuss potential roles for lysolipid signaling in the vasculature and mechanisms by which these bioactive lipids could contribute to cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19630765      PMCID: PMC2801156          DOI: 10.1111/j.1538-7836.2009.03405.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  45 in total

Review 1.  Regulation of immunity by lysosphingolipids and their G protein-coupled receptors.

Authors:  Edward J Goetzl; Hugh Rosen
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

2.  Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.

Authors:  Ahmed Boucharaba; Claire-Marie Serre; Sandra Grès; Jean Sébastien Saulnier-Blache; Jean-Claude Bordet; Julien Guglielmi; Philippe Clézardin; Olivier Peyruchaud
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

3.  Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions.

Authors:  W Siess; K J Zangl; M Essler; M Bauer; R Brandl; C Corrinth; R Bittman; G Tigyi; M Aepfelbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

4.  Platelet-derived lysophosphatidic acid decreases endothelial permeability in vitro.

Authors:  J S Alexander; W F Patton; B W Christman; L L Cuiper; F R Haselton
Journal:  Am J Physiol       Date:  1998-01

Review 5.  Mechanisms of lysophosphatidic acid production.

Authors:  Junken Aoki
Journal:  Semin Cell Dev Biol       Date:  2004-10       Impact factor: 7.727

6.  Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype.

Authors:  Brian R Wamhoff; Kevin R Lynch; Timothy L Macdonald; Gary K Owens
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-05       Impact factor: 8.311

7.  The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak.

Authors:  Andrew M Tager; Peter LaCamera; Barry S Shea; Gabriele S Campanella; Moisés Selman; Zhenwen Zhao; Vasiliy Polosukhin; John Wain; Banu A Karimi-Shah; Nancy D Kim; William K Hart; Annie Pardo; Timothy S Blackwell; Yan Xu; Jerold Chun; Andrew D Luster
Journal:  Nat Med       Date:  2007-12-09       Impact factor: 53.440

8.  Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs.

Authors:  Hidenobu Kanda; Rebecca Newton; Russell Klein; Yuka Morita; Michael D Gunn; Steven D Rosen
Journal:  Nat Immunol       Date:  2008-03-09       Impact factor: 25.606

9.  Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.

Authors:  Jeniter E Hughes; Suseela Srinivasan; Kevin R Lynch; Richard L Proia; Pawel Ferdek; Catherine C Hedrick
Journal:  Circ Res       Date:  2008-03-06       Impact factor: 17.367

10.  Vascular endothelium as a contributor of plasma sphingosine 1-phosphate.

Authors:  Krishnan Venkataraman; Yong-Moon Lee; Jason Michaud; Shobha Thangada; Youxi Ai; Herbert L Bonkovsky; Nehal S Parikh; Cheryl Habrukowich; Timothy Hla
Journal:  Circ Res       Date:  2008-02-07       Impact factor: 17.367

View more
  20 in total

1.  Granule-mediated release of sphingosine-1-phosphate by activated platelets.

Authors:  Deepa Jonnalagadda; Manjula Sunkara; Andrew J Morris; Sidney W Whiteheart
Journal:  Biochim Biophys Acta       Date:  2014-08-23

2.  Lysophosphatidic acid and cardiovascular disease: seeing is believing.

Authors:  Andrew J Morris; Susan S Smyth
Journal:  J Lipid Res       Date:  2013-03-18       Impact factor: 5.922

3.  Autotaxin and its product lysophosphatidic acid suppress brown adipose differentiation and promote diet-induced obesity in mice.

Authors:  Lorenzo Federico; Hongmei Ren; Paul A Mueller; Tao Wu; Shuying Liu; Jelena Popovic; Eric M Blalock; Manjula Sunkara; Huib Ovaa; Harald M Albers; Gordon B Mills; Andrew J Morris; Susan S Smyth
Journal:  Mol Endocrinol       Date:  2012-04-03

4.  Role of soluble epoxide hydrolase phosphatase activity in the metabolism of lysophosphatidic acids.

Authors:  Christophe Morisseau; Nils Helge Schebb; Hua Dong; Arzu Ulu; Pavel A Aronov; Bruce D Hammock
Journal:  Biochem Biophys Res Commun       Date:  2012-02-24       Impact factor: 3.575

Review 5.  Lysophospholipid mediators in the vasculature.

Authors:  Paul Mueller; Shaojing Ye; Andrew Morris; Susan S Smyth
Journal:  Exp Cell Res       Date:  2015-03-28       Impact factor: 3.905

6.  Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway.

Authors:  Bin Ren; James Hale; Sowmya Srikanthan; Roy L Silverstein
Journal:  Blood       Date:  2011-03-25       Impact factor: 22.113

7.  LPA/PKD-1-FoxO1 Signaling Axis Mediates Endothelial Cell CD36 Transcriptional Repression and Proangiogenic and Proarteriogenic Reprogramming.

Authors:  Bin Ren; Brad Best; Devi Prasadh Ramakrishnan; Brian P Walcott; Peter Storz; Roy L Silverstein
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-03-24       Impact factor: 8.311

8.  LPA receptor 4 deficiency attenuates experimental atherosclerosis.

Authors:  Liping Yang; Maria Kraemer; Xianjun Frank Fang; Peggi M Angel; Richard R Drake; Andrew J Morris; Susan S Smyth
Journal:  J Lipid Res       Date:  2019-02-22       Impact factor: 5.922

9.  Metabolomic profiling in liver of adiponectin-knockout mice uncovers lysophospholipid metabolism as an important target of adiponectin action.

Authors:  Ying Liu; Sanjana Sen; Sivaporn Wannaiampikul; Rengasamy Palanivel; Ruby L C Hoo; Ruth Isserlin; Gary D Bader; Rungsunn Tungtrongchitr; Yves Deshaies; Aimin Xu; Gary Sweeney
Journal:  Biochem J       Date:  2015-04-27       Impact factor: 3.857

Review 10.  Role of platelets in neuroinflammation: a wide-angle perspective.

Authors:  Lawrence L Horstman; Wenche Jy; Yeon S Ahn; Robert Zivadinov; Amir H Maghzi; Masoud Etemadifar; J Steven Alexander; Alireza Minagar
Journal:  J Neuroinflammation       Date:  2010-02-03       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.